Back to top

Biohaven price target raised to $23 from $22 at RBC Capital

RBC Capital raised the firm’s price target on Biohaven (BHVN) to $23 from $22 and keeps an Outperform rating on the shares. The firm cites the comp...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Biohaven Ltd. (BHVN)